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Perturbation of physiological processes stimulate a cascade of events 
resulting in adverse pathogical conditions, the most predominant being cancer. 
Colorectal cancer (CRC) is the third most common cancer in the United States 
and the second leading cause of cancer-related deaths.  CRC is most commonly 
initiated by loss of function mutations of Adenomatous polyposis coli (APC), a 
tumor suppressor gene of the Wnt/B-catenin pathway, which leads to constitutive 
activation of Wnt signaling. Although significant progress has been made in 
understanding the sequential genetic events leading to cancer development, the 
precise genes and associated molecular events underlying tumor progression 
are still poorly understood. Our lab has previously reported a correlation between 
increased expression of claudin-1, a tight junction protein, in primary and 
metastatic tumor samples of CRC patients (Dhawan et al., 2005). Additionally, in 
adenomas of the APCMin mouse, an experimental model for CRC, and human cell 
lines harboring mutations in APC, claudin-1 expression is highly increased and 
mislocalized. Taken together, these studies suggest existence of a potential 
interplay between dysregulated claudin-1 expression and APC, thus supporting 
an essential role for claudin-1 in the regulation of sporadic colonic neoplasia. In 
addition to genetic stimuli, CRC can be initiated by an inflammatory stimulus.  
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Patients with inflammatory bowel disease (IBD), a chronic disorder of the 
gastrointestinal tract, are at high risk for developing CRC. This may be attributed, 
in part, to repeated injury and repair, which induces transformation of the colonic 
epithelium. As such, increased Claudin-1 expression is also reported to be 
associated with active IBD and colitis-associated cancer, yet its distinct role in 
inflammation has yet to be elucidated. The purpose of this study is to identify the 
specific contribution that increased expression of a tight junction protein, claudin-
1, brings to inflammation and CRC.  
Tight Junctions 
Cellular adhesion molecules are an important aspect of cell biology as 
they are essential to the formation of close contacts between adjacent cells.  In 
the case of epithelial cells, these cell-cell contacts facilitate the formation of 
epithelial sheets, which constitute the surface and lining of organs throughout the 
body.  The cellular adhesion molecules are composed of desmosomes, gap 
junctions, adherens junctions and the tight junctions. The tight junctions are the 
most apical of the cell-cell contacts, located at the “kissing” point between cells.  
They play major roles in regulating cellular polarity and paracellular permeability.  
In the context of cellular polarity, tight junctions serve as a molecular “fence” 
helping to maintain the segregation of apical and basolateral proteins (Shin et al., 
2006).  More studied is their barrier function, regulating cellular permeability, in 
which tight junctions serve as molecular “bouncers”, permitting or restricting the 
passage of ions, nutrients, and luminal antigens across the epithelium (Balda et 









Figure 1. Schematic of Tight Junctions 
The tight junctions reside at the most apical region of cellular junctions.  They consist of 
claudins, JAMs, and occludin proteins.  Peripheral tight junction proteins, ZO family, bind 
to membrane spanning junctions, and serve as connection to the actin cytoskeleton. 
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The tight junctions are composed of transmembrane spanning proteins  
and peripheral proteins, which rest near the surface of the cytosolic membrane 
(Figure 1).  The most common peripheral tight junctions include those of the zona 
occludens family, ZO-1, -2, and -3 (Shin et al., 2006).    The transmembrane 
proteins consist of three major families: junctional adhesion molecules (JAMs), 
occludin, and claudins. The claudin family is made of approximately 27 members 
with molecular weights ranging between 20-27 kDa. These proteins are made of 
four transmembrane domains, with their N- and C- terminal ends located in the 
cytoplasm. The C-terminus contains a binding site for the interaction with other 
proteins, including those containing PDZ binding domains that serve as a direct 
connection to the actin-cytoskeleton, and also contains residues that serve as 
sites for post-translational modifications.  The claudins are expressed 
ubiquitously throughout various organs of the body facilitating cell-cell 
connections among epithelial and endothelial cells and have the ability to form 
homodimers and heterodimers.  These interactions and varied expression 
patterns help confer special properties to the function of the organ.  For example, 
claudin-7 has been shown to regulate paracellular conductance of sodium ions in 
kidney cells (Alexandre et al., 2005), and claudin-2 can regulate permeability and 
cation selectivity in the kidney (Muto et al., 2010). Claudin-1 plays a critical role in 
regulating barrier function in the skin and kidney (Tsukita and Furuse, 1998), 
(Inai et al., 1999). 
Claudin-1 was the first of the claudins to be identified, alongside Claudin-
2, in key experiments demonstrating that apical junctions were still able to form 
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during development, even in the absence of occludin, which was thought to be 
the sole integral membrane tight junction at the time (Furuse, 1998).  Subsequent 
studies further demonstrated the importance of claudin-1 in regulating barrier 
function whereby overexpression of claudin-1 was able to increase transepithelial 
resistance (TER) and decrease paracellular permeability (Inai et al., 1999). The 
physiologic importance of claudin-1 was made even more evident by the 
generation of the Claudin-1 knockout mouse.  These mice died within one day of 
birth due to epithelial barrier defects and dehydration, which showed its necessity 
for normal barrier function (Furuse et al., 2002).  As indicated above, tight 
junctions, claudins in particular, are essential to the integrity of the epithelium and 
the organisms as a whole. Disruption of these cellular contacts can upset 
homeostatic interactions that prove detrimental to the organism.  The intestine is 
one organ that depends heavily upon the function of the tight junctions. 
Colonic homeostasis 
The colonic epithelium exists in a delicate balance between millions of 
bacteria and antigens in the lumen and the immune regulating cells that reside in 
the lamina propia. Claudins help to regulate this balance by maintaining cellular 
polarity and barrier dynamics.  
 Another important aspect of epithelial homeostasis is the mucous barrier.  
The mucosal barrier aids in the luminal defense against environmental factors, 
bacterial invasion, and protection of the epithelium against injury (Hasnain et al., 
2010), (McGuckin et al., 2011), (Hollingsworth and Swanson, 2004), (Kufe, 
2009).  Second to the tight junction, it helps maintain integrity of the epithelial 
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barrier.  The primary constituents of the mucosal barrier are a family of 
glycoproteins termed Mucins. The primary secreted mucin, Muc2, has been 
extensively implicated in IBD and colorectal cancer.  Muc2 deficient mice develop 
colitis, spontaneously, and enhance the development of colon cancer suggesting 
an essential role of Muc2 in epithelial homeostasis and disease progression (van 
der Sluis et al., 2006), (K. Yang et al., 2008).  Mucins are secreted by specialized 
intestinal goblet cells and assemble to form the mucosal barrier that overlays the 
epithelium.  This introduces yet another level of homeostatic control involving the 
colonic epithelium itself.   
Differentiation of the colonic epithelium is tightly regulated by molecular 
cues at play in the colonic crypts.  These cues predominately arise from the Wnt 
and Notch pathways.  Active Wnt signaling is concentrated to the base of the 
crypt in rapidly proliferating cells, helping to maintain the stem cell population.  
Along the crypt axis, from the base of the crypt upwards, Wnt cues gradually 
taper off, regulating expression of genes within the epithelial cell that leads to a 
state of terminal differentiation.  The stem cells of the crypt give rise to transit-
amplifying cells.  It is after this stage that Notch signaling determines the cell fate 
between the secretory and absorptive cell lineages.  The absorptive lineage 
gives rise to terminally differentiated colonocytes. The secretory lineage 
produces hormone secreting enteroendocrine cells and the mucous secreting 








Figure 2. Epithelial Differentiation of the Colon 
The stem cells of the colonic crypt give rise to transit-amplifying cells.  These cells 
give rise to cell types of the absorptive lineage or the secretory lineage.  Absorptive 
cells of the colon are colonocytes, identified by the marker carbonic anhydrase.  
Cells of the secretory lineage produce mucous secreting goblet cells that are 
characterized by Muc2, Klf4 and Tff3 gene expression.  Enteroendocrine cells are 
secretory cells identified by expression of neurogenin 3 (Ngn3), and Chromagranin 
A (CgnA). 
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Notch activation is initiated by the interaction of the NOTCH ligand (Delta-
like ligand -1, -3, or -4 and JAG1, JAG2) with a NOTCH receptor (NOTCH 1-4) of 
an adjacent cell.  This interaction facilitates a series of proteolytic cleavages that 
results in the release of the Notch Intracellular Domain (NICD) to translocate to 
the nuclease and bind its transcriptional cofactor, CSL. This complex will bind 
DNA and activate transcription of the HES/HEY family of transcriptional 
repressors.  Hes1 in turn inhibits expression of Math1.  Math1 is a gene that is 
responsible for the transcription of Mucin2, the primary constituent of the mucous 
secreting goblet cells. Several components of the Notch signaling have been 
shown to be upregulated in CRC (Reedijk et al., 2008).  More recent studies 
have investigated targeting Notch pathway components as a strategy to inhibit 
colon tumorigenesis (Miyamoto et al., 2013), (Sonoshita et al., 2011).  
Additionally, the Notch pathway has been implicated in inflammatory bowel 
disease as being crucial to regeneration of colonic epithelium after injury 







Figure 3. Notch Signaling Overview 
During epithelial differentiation, when Notch signaling is in the “OFF” state Hes1 
expression is repressed and cells continue to express Math1, which give rise to 
specialized secretory cells.  When Notch signaling is activated to the “ON” state, a 
series of proteolytic cleavages release Notch Intracellular Domain (NICD), facilitating 
translocation to the nucleus and binding to CSL.  This activates the Hes1 
transcriptional repressor to inhibit Math1 expression, causing cells to give rise to the 
absorptive lineage. 
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Claudins in disease 
Defective barrier function has been shown to result in a myriad of 
diseases including inflammatory bowel disease (Laukoetter et al., 2008), atopic 
dermatitis (Hogan et al., 2012), deafness (Gow et al., 2004), (Ben-Yosef et al., 
2003), and jaundice of the liver including primary biliary cirrhosis and primary 
sclerosing cholangitis (Sawada, 2013). Based on the function of claudins and 
tight junctions in colonic homeostasis, it can be appreciated how their 
dysregulation can result in adverse effects to the epithelium, the organ in which it 
protects, and the organism as a whole. Additionally, dysregulated junctions can 
also lead to a loss in polarity, creating an EMT-like condition, that induces de-
differentiation and transformation of cells that can lead to accelerated tumor 
growth and progression (Singh et al., 2010).  Claudins are able to regulate each 
of these processes in addition to regulating proliferation, differentiation (Tsukita 
et al., 2008),(Pope et al., 2013), migration (Ikari et al., 2011), and invasion 
(Oliveira and Morgado-Diaz, 2007), (Morin, 2005).  Their differential expression 
in various cancer models has been shown to correlate with disease severity, and 
in some cases, advanced staging of tumor progression.  Increased expression of 
Claudin-1, in particular, has been associated with disease severity in intestinal 
inflammation and colon cancer.  
Intestinal Inflammation 
Breeches in barrier dynamics can result in a shift in homeostasis of the 
affected tissue that can lead to inflammation, as is the case in the colon and the 
development of inflammatory bowel disease (IBD).  Inactivity of the tight junction 
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associated protein Myosin-light chain Kinase (MLCK) was sufficient to alter 
immune regulation and enhance susceptibility to colitis (Su et al., 2009). 
Additionally, genetic depletion of claudin-7 in the intestine resulted in increased 
inflammation and epithelial sloughing, reminiscent of symptoms associated with 
IBD (Ding et al., 2012).  IBD is a broad classification for a group of chronic 
inflammatory disorders affecting the gastrointestinal tract, the most common 
being Chron’s Disease and Ulcerative Colitis.  Although colitis can be inherited, 
this is only the case for a small percentage (less than 10%) of affected 
individuals.  As such, the majority of patients acquire the disease spontaneously. 
Since the exact etiology of IBD is unknown, there is no known cure. Some 
therapies, that target the inflammation, are employed to temporarily alleviate 
active disease.  Most patients become accustomed to management of the 
disease through diet, yet even this does not prevent recurring inflammation.  
Many patients will develop this disease as young adults and may suffer years of 
successive rounds of inflammation and epithelial repair, which puts them at high 
risk for developing colorectal cancer.  There have been many studies undertaken 
to identify the initiating stimulus of colitis, and most have resulted in adding 
significant knowledge to the field. However, the vast number of studies have only 
highlighted the complexity of this disease.  Genetic mutation, environmental 
stimuli, dysregulation of the immune system, and contribution of the commensal 
bacteria are all factors that have been investigated and suggested to play a role, 
singularly or in concert, in the development of IBD.  
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Surprisingly, there are few studies that show claudin deficiency leading to 
spontaneous disease.  Some, however, have identified their dysregulation during 
disease.  Increased expression of claudin-1 and claudin-2 was observed in active 
inflammatory bowel disease of human patient samples (Weber et al., 2008), and 
changes in Claudin-5 and -8 expression have been associated with Chron’s 
disease (Zeissig et al., 2007).  In an attempt to reconcile these changes, studies 
have shown that inflammatory components such as TNFa, IL-6 and IFNy can 
regulate claudin expression (T. Suzuki et al., 2011), (Shiozaki et al., 2012), 
(Tedelind et al., 2003), suggesting a potential mechanism for altered expression 
of tight junctions in IBD. 
Colorectal Cancer 
Colorectal cancer (CRC) is the third most common cancer in the United 
States.  CRC can be initiated by an inflammatory stimulus, known as colitis-
associated cancer, or can be acquired spontaneously, as is the case in over 75% 
of the total CRC cases.  Over 90% of sporadic colorectal cancer cases occur in 
patients having a hereditary disease known as Familial Adenomatous polyposis 
(FAP), in which only one copy of the APC allele is inherited.  The APC protein is 
a key player in the Wnt signaling pathway.  It assembles with other proteins to 
make up the b-catenin destruction complex, which is responsible for the 
continued degradation of b-catenin in the absence of Wnt ligand.  Upon Wnt 
stimulation, the APC complex disassembles, facilitating accumulation of b-
catenin and interaction with transcription cofactors TCF/LEF to activate 
expression of genes that regulate cell cycle dynamics.  Extensive research has 
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shown that the constitutive activation of the Wnt signaling pathway, either by loss 
of APC or activating mutations in b-catenin, is most frequently associated with 
development of colorectal cancer.  
Claudin-1 has been identified as a target gene of Wnt signaling.  Its 
promoter contains two putative TCF/LEF binding sites to which β-catenin can 
bind and activate transcription (Miwa et al., 2001).  To this end, increased 
claudin-1 expression has been frequently observed in colorectal cancer (Resnick 
et al., 2005), (Huo et al., 2009).  Primary tumor samples obtained from human 
patients exhibit elevated claudin-1 protein expression compared to adjacent 
normal tissue (Dhawan et al., 2005).  Claudin-1 expression was further 
upregulated in metastatic tissue samples obtained from the same patients.  
Additionally, in APCMin mice, claudin-1 expression is elevated in intestinal 
adenomas compared to adjacent normal tissue.  Even more surprising, genetic 
modulation of claudin-1 in human colon cancer cells was sufficient to regulate 
primary tumor growth and metastasis in mouse xenograft studies.  
Dysregulated claudin-1 expression is not only restricted to spontaneous 
cancers.  Analysis of patient samples showed increased expression of claudin-1 
in colitis-associated CRC(Kinugasa et al., 2010).  This type of CRC is acquired 
by patients who endure years of chronic inflammatory disease, which eventually 
leads to transformation of the colonic epithelium.  Indeed, claudin-1 expression is 
upregulated in patients with chronic inflammatory disease, and more interestingly 
in areas of dysplasia (Weber et al., 2008).  As such, understanding the role of 
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tight junctions, and specifically that of claudin-1, in inflammation will also aid in a 
better understanding of its role in CRC. 
Purpose/Significance 
 Developing successful therapeutic strategies to prevent and combat 
colorectal cancer requires a better understanding of the processes that leads to 
tumor progression. Claudin-1 expression is upregulated in CRC and has been 
shown to regulate tumorigenic potential of CRC cells.  Additionally, it is 
upregulated in colitis-associated cancer, and correlates with active IBD. The 
purpose of this study is to identify the specific contribution that increased claudin-
1 expression brings to CRC.  Thus, our hypothesis is that claudin-1 
overexpression contributes to the colon carcinogenesis when combined with a 
CRC initiating genetic mutation such as APC mutation. Additionally, as 
inflammation can be a precursor to CRC development, we predict increased 
expression of claudin-1 will also contribute to inflammation. These studies will 
impact the current understanding of the role of tight junction proteins in the 
regulation of sporadic CRC especially in collaboration/association with APC 
mutation and inflammatory disease.  Most importantly, this work will help to seek 









CLAUDIN-1 REGULATES INTESTINAL EPITHELIAL HOMEOSTASIS 
THROUGH THE MODULATION OF NOTCH SIGNALING 
 
Introduction 
Inflammation of the underlying colonic mucosa is a key characteristic of 
inflammatory bowel diseases (IBD) including Crohn’s disease (CD) and 
ulcerative colitis (UC). Although the etiology of IBD remains unknown, 
malfunctioning of the colonic epithelial barrier has emerged as a key 
characteristic of the IBD pathogenesis (Turner, 2009).  The general postulation is 
that dysregulated mucosal barrier facilitates the access of the luminal antigens 
across the epithelium and thus induces immune activation and thereby 
inflammation (Chichlowski and Hale, 2008). 
The mucosal barrier consists primarily of two key constituents: 
extracellular mucus consisting primarily of the glycoprotein mucin-2 (muc-2) 
secreted by the goblet cells, and the single layer of epithelium (Kufe, 2009).  
Tight junctions, the most apical cell-cell adhesions, are the primary regulators of 
the epithelial barrier function (Singh et al., 2010).  Indeed, modulation of the muc-
2 expression, goblet cell number and tight junction (TJ) integral proteins are 
known characteristics of IBD patients (Maloy and Powrie, 2011).  Furthermore, 
mice deficient in muc-2 protein demonstrate an elevated production of pro-
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inflammatory cytokines and develop colitis spontaneously (van der Sluis et al., 
2006). In the colon, Notch activation modulates muc-2 expression, expression of 
tight junction proteins, and the balance between proliferation and differentiation in 
the enterocyte progenitor pool (Dahan et al., 2011; Qiao and Wong, 2009; 
Sikandar et al., 2010; Zheng et al., 2011). 
The claudin family of proteins is an integral component of the structure 
and function of TJs. The 27 known claudin family members are expressed 
differentially among various tissues and their expression can be altered under 
pathological conditions including inflammatory disorders such as IBD and cancer 
(Singh et al., 2010).  Notably, expression of the claudin-1 protein is increased in 
the areas of active inflammation (Weber et al., 2008).  Of interest, a correlation 
between increased claudin-1 expression and neoplastic transformation was also 
noted in colitis-associated cancer (Kinugasa et al., 2010).  Also, loss of claudin-1 
leads to severe dehydration and post-natal death in mice (Furuse et al., 2002).  
We have reported a causal association of claudin-1 expression with sporadic 
colon cancer growth and progression (Dhawan et al., 2005). However, the role of 
claudin-1 in the regulation of epithelial homeostasis, mucosal inflammation and 
IBD remains unknown.  
In the current study, using mice with intestinal specific overexpression of 
Claudin-1 as a model, we report a previously unknown role of claudin-1 in the 
regulation of Notch-signaling and colonic epithelial homeostasis. We 
demonstrate that colonic claudin-1 overexpression increases MMP-9 and p-ERK 
expression, Notch-signaling and the overall colonocyte population while 
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decreasing the goblet cell number and muc-2 expression. We further 
demonstrate that Cl-1Tg mice are susceptible to colitis induced using dextran 
sodium sulfate (DSS) and demonstrate sustained inflammation and hyperplasia 
even when subjected to recovery following DSS-colitis.  
 
Materials and Methods 
 
Generation and characterization of Claudin-1 Transgenic Mice 
The human claudin-1 cDNA was cloned into the pBS plasmid vector under 
the control of the intestine specific villin promoter, a generous gift from Dr. Sylvie 
Robine (Marjou et al., 2004).  Two Villin-claudin-1 positive founder lines were 
obtained on a C57BL/6 genetic background.  Mice were maintained following the 
Institutional Animal Care and Use Committee (IACUC) guidelines of Vanderbilt 
University. Cl-1Tg mice were maintained in the C57BL/6 background, and 
offspring genotyped using DNA isolated from the tail genomic DNA.  Presence of 
the transgene was verified by PCR using two different PCR primer sets (Table 1).   
Induction of Colitis by Dextran Sodium Sulfate 
Eight- to ten-week-old mice were used for all studies unless noted 
otherwise.  Mice received standard chow diet during the experiment.  Control 
mice received untreated water ad libitum and the colitis group received indicated 
amounts of DSS dissolved in water as described in details in the supplemental 
material.  
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Measurement of Colitis Severity and Histological Scoring 
Colitis severity was estimated by measuring body weight loss, colon 
length, and colon weight.  Paraffin-embedded sections were stained for H&E or 
with antibodies to indicated proteins (Table 2).  Blinded to genotype and 
treatment, H&E stained sections were scored for parameters quantifying colitis, 
which include inflammation and crypt damage.  Categories were given a score 
range from 0 to 4 as indicated.   
Statistical Analysis 
Graphpad Prism 5 was used for statistical analysis (San Diego, CA). Data 
were analyzed using a student t-test or Newman-Keuls post test following one-
way analysis of variance.  Data are expressed as means ± SEM.  P values less 
than 0.05 were considered significant. 
Cell Culture and Transfection 
The human colon cancer cell lines, SW480 and LS174T were obtained 
from ATCC and cultured in RPMI containing 10% FBS.  SW480Claudin-1 cells have 
been described previously (Dhawan et al., 2005).  Stable polyclonal cells, 
LS174TClaudin-1 were obtained in the same manner.  Stable cell lines were 
maintained using neomycin as the selection reagent.  For inhibitor treatments, 
cells were seeded in six-well cell culture plates to final density of 60% confluence 
before adding indicated amounts of inhibitor for the indicated time points.   
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Experimental Colitis 
During DSS treatment, mice were monitored daily for signs of distress 
including, excessive loss of weight (20%), hunched posture, and bloody stool.  
Mice reaching critical weight loss were sacrificed according to IACUC guidelines.   
Tissue Harvesting 
Following sacrifice, the small intestine and colon were dissected, flushed 
with PBS, opened flat, and formalin-fixed via the Swiss roll method.  Samples 
were further processed by the Vanderbilt Translational Pathology Shared 
Resource Core.  Distal and proximal ends of the colon were snap-frozen in liquid 
nitrogen.  Other tissues harvested for protein expression were also processed in 
this manner.   All frozen tissues were stored at  -80ºC until further analysis.   
Immunostaining 
Paraffin-embedded tissues were de-pariffinized with xylene and 
successive ethanol washes.  Antigen unmasking was performed using 10mM 
sodium citrate buffer (pH 6.0).  Immunostaining was performed using the 
indicated antibodies (Table 1) and VectaStain ABC kit (Vector Laboratories) was 
used for brown staining.  FITC and Rhodamine conjugated antibodies against 
mouse and rabbit antibodies (Jackson laboratories) were used for 
immunofluorescence staining.  Images were obtained using a Zeiss light 
microscope or Confocal microscopy (LSM 510) in part through the use of the 
VUMC Cell Imaging Shared Resource.  For PAS immunostaining, cells were 
plated on glass chamber slides and treated as mentioned previously.  Upon 
termination of treatment, cells were fixed for 15 min and room temperature with 
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ethanol-acetic acid (3:1), then stained with periodic acid solution for 5 min at 
room temperature.   Slides were then washed with tap water to remove excess 
stain and incubated with Schiffs reagent for 15 min at room temperature.  After 
washing with tap water for 5 min, cells were counterstained with hematoxylin.  
RNA Isolation for quantitative RT-PCR 
Total RNA from mouse samples was extracted using 20-30mg of tissue 
from the distal colon using the RNeasy Mini Kit (Qiagen) with DNAse digestion.  
RNA integrity was determined by formaldehyde gel electrophoresis and 
absorbance spectroscopy.  Samples presenting two bands, corresponding to the 
18S and 28S subunits, and having an A260/A280 of ~1.8 were used for 
experiments. 
Quantitative RT-PCR 
Total RNA (1ug) of each sample was reverse transcribed using the iScript 
cDNA Synthesis Kit (Bio-Rad).  PCR reactions were performed using gene-
specific primers (Table 2).  Each well contained SYBR Green Master Mix 
(Qiagen), primer sets and cDNA (30ng).  Samples were loaded in triplicates or 
quadruplicates in 96 well plates and run on a Bio-Rad iCycler. Ct values were 
utilized to calculate fold change.  Normalization was performed using beta-actin.   
Immunoblot analysis 
Cells were lysed in radioimmunoprecipitation assay buffer, and Western 
blotting was performed as previously described (Dhawan et al., 2005).  Antibody 
information can be obtained in Table 1. 
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In vivo Permeability Assay 
Mice were administered 4 kDa FITC-dextran via enema to measure 
permeability.  Mice were anesthetized and blood taken at baseline and thirty 
minutes following rectal administration from the retro-orbital sinus of the eye.  
Serum was collected from the blood via centrifugation.   Samples were measured 
for fluorescence using a microplate fluorescence reader (BIO-TEK) at an 
excitation wavelength of 485 nm and an emission wavelength of 528 nm. The 
concentration was determined using a standard curve.   
Ussing Chamber Studies 
Distal colon segments were harvested from mice and mounted in Ussing 
chambers (Physiologic Instruments, Inc., San Diego, CA).  Samples were 
mounted between the two halves the Ussing chamber (0.1-cm2 opening).  The 
mucosal and serosal sides of the chambers were filled with 5mL of Ringer’s 
solution (150 mM NaCl, 2 mM CaCl2, 1mM MgCl2, 10mM mannitol, 10mM 
glucose, and 10mM Tris-HEPES, pH 7.4). The ringer solution was continuously 
oxygenated with 100% O2 bubbled through solution.  After allowing 20 minute 
equilibration period to measure baseline potential difference and resistance, 
4kDa FITC Dextran (Sigma) was added to the mucosal compartment.  Two-
hundred microliter samples were taken every 15 minutes from the serosal 
compartment for analysis and replaced by fresh Ringer solution.  Permeability 
was determined at the end of the 120-min experimental period and assessed for 
fluorescence in a microplate fluorescence reader (BIO-TEK). 
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Electron Microscopy  
Colon tissue from WT and Tg mice were processed and photomicrographs 
were obtained/analyzed through the assistance of the VUMC Cell Imaging 
Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, 













Characterization of the Cl-1Tg mice 
  Claudin-1 expression is upregulated under multiple intestinal pathological 
conditions including IBD and colorectal cancer (Dhawan et al., 2005; Kinugasa et 
al., 2010; Weber et al., 2008).  We further confirmed increased claudin-1 
expression in Crohn’s disease and Ulcerative colitis patient samples (Figure 4).  
To further investigate the role of claudin-1 in intestinal homeostasis, we 
developed Cl-1Tg mice using a construct in which the human claudin-1 cDNA 
was placed under the control of the murine intestine-specific villin promoter 
(Figure 5A).  As predicted, robust claudin-1 overexpression was observed in the 
colon, small intestine, and cecum of the transgenic mice (Figure 5B), but not in 
other organs (Figure 6A). Immunohistochemical analysis using anti-claudin-1 
antibody further confirmed the increase in claudin-1 expression, and indicated 
that it was localized largely to the membrane and throughout the entire crypt in 
Cl-1Tg mice (Figure 5C).   
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Figure 4.  Representative patient samples from normal, Ulcerative Colitis, 
and Chron’s Disease 
Representative patient samples from normal, Ulcerative colitis and Crohn’s disease 
patient. IHC staining for claudin-1 was performed using archived paraffin sections of 
normal controls, Crohn’s disease (CD) and ulcerative colitis (UC) (n=5-6) and 
quantitation depicted in the table as % samples (number of samples). Interestingly, 
increased claudin-1 immunostaining either appeared membrane bound (though it was 
localized rather laterally between the epithelial cells) or membrane localization was 






Figure 5. Generation of Claudin-1 Transgenic mice 
(A) Schematic of Villin-claudin-1 expression vector.  (B) Immunoblot analysis using 
tissue lysates from wild type (WT) and Cl-1Tg mice were utilized to determine the 
expression of Claudin-1 expression.  β-actin was used as loading control. MDCK cell 
lysate served as positive control. (C) Immunostaining for claudin-1 in the small intestine 
and colon of WT and Cl-1Tg mice. (D) Representative H&E staining for the colon of WT 
and Cl-1Tg mice.  (E) Immunoblot analysis; and (F) Immunostaining for tight junctions 
and adherens junctions proteins in WT and Cl-1Tg mice. 
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Figure 6. Expression analysis of Cl-1Tg mice 
(A) Tissue lysates from indicated organs of wild type (WT) and Cldn-1TG (Tg) mice were 
tested for Claudin-1 expression.  Actin was used as a loading control and MDCK cell 
lysate was used as positive control.  (B) Immunostaining for claudin-15 and occludin in 




The claudin family comprises 27 known members, which form homo and hetero-
dimers (Niessen, 2007).  Genetic manipulation of specific claudin family 
members alters expression of other claudin family members, possibly due to 
compensation. Therefore, we sought to determine whether claudin-1 
overexpression alters expression of other claudins and/or E-cadherin and β-
catenin.  Both immunoblot and immunofluorescence analysis using colons from 
Cl-1Tg and WT mice demonstrated decrease in claudin-7 expression while 
expression of claudin-3,-4,15, Occludin, E-cadherin, and β-catenin remained 
largely unaltered (Figure 5E, 5F and 6B).  
 Next, we examined the effects of claudin-1 overexpression upon TJ 
structure and function. Electron microscopic examination revealed no significant 
morphological changes in the TJ structure of the colonic epithelial cells between 
age- and sex-matched WT and Cl1-Tg mice. Similarly, epithelial permeability as 
determined by rectal administration or Ussing chamber analysis using FITC-
dextran (4 kDa) was not altered between WT and Cl-1Tg mice. However, trans-
epithelial resistance (TER) increased in Cl-1Tg mice versus WT-littermates 




Figure 7. Claudin-1 overexpression does not alter tight junction function 
in mice 
(A) Representative photomicrographs of Electron microscopy images of WT and Tg 
colons. (B) FITC-dextran flow as assessed via FITC-dextran permeability assay in WT 
and Tg mice. 
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Claudin-1 overexpression altered epithelial cell differentiation  
Although, Cl-1Tg mice did not differ from WT mice in their appearance 
and/or gross physiology, histological evaluation suggested potential alteration in 
the goblet cell number in the colon of Cl-1Tg mice versus WT mice (Figure 5D).  
To evaluate further, we performed Periodic Acidic Schiff (PAS) staining for 
mucins produced by goblet cells in small intestine (SI) and colon (Figure 8A,B).  
Indeed, a decrease in number of PAS-positive cells in the SI and colon of the Cl-
1Tg mice compared to WT mice was observed (Figure 9A, p<0.001). To further 
confirm, Alcian blue staining was used to identify acidic proteins commonly found 
in mucus-containing cells (Figure 9B). Among the mucins that constitute the 
colonic mucus barrier, Muc-2 is the most abundant(Coant et al., 2010; Kufe, 
2009) and is often used as a marker of goblet cell homeostasis. Therefore, we 
further performed immunohistochemical analysis to examine muc-2 expression in 
the colon of Cl-1Tg and WT mice. We documented a significant decrease 
(p<0.0001) in muc-2 positive cells in the colon of Cl-1Tg mice compared to WT 
mice (Figure 8B and 9A).  
The secretory goblet cells are one of the four cell types within the 
intestinal epithelium (van der Flier and Clevers, 2009).  To determine whether 
other cell types of the absorptive or secretory lineages were also altered, we 
performed immunohistochemical analysis using Carbonic Anhydrase-I (marker of 
colonocytes) and Chromagranin-A (marker of enteroendocrine cells).  We 
detected an increase in carbonic anhydrase staining in the colon of Cl-1Tg mice 
versus WT mice (Figure 8B).  A slight increase in Chromagranin-A positive cells 
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was also observed in the small intestine and colon of the Cl-1Tg mice and WT 
mice (Figure 8A,B). Staining for lysozyme (marker for Paneth cells; small 
intestine) did not detect major changes in Cl-1Tg mice compared to WT mice 
(Figure 8A).  Overall, intestinal overexpression of claudin-1 appeared to have 
altered the epithelial lineage commitment in the mouse colon and small intestinal 
epithelium.  
The molecular/signaling mechanism/s that regulate colonic epithelial cell 
differentiation are also important in the regulation of colonic epithelial 
proliferation. Therefore, we determined the potential effect of the colonic claudin-
1 overexpression on proliferation. We observed a significant increase in 
proliferation in the colon of Cl-1Tg mice compared to the colon of WT mice 
(Figure 8C, p<0.001). Further determination of the pathways involved in cell 
proliferation/apoptosis demonstrated a marked increase in the phosphorylation of 




Figure 8. Claudin-1 overexpression alters intestinal epithelial cell 
lineage and increases proliferation.   
(A) Immunostaining for PAS, Lysozyme, and Chromagranin-A in small intestine; 
(B) Immunostaining for PAS, Muc-2, Carbonic Anhydrase-I, and Chromagranin-A 
in colon; (C) Immunostaining of colon for BrdU incorporation and quantification; 
and (D) Immunoblot and immunostaining to determine p-ERK expression in WT 




Figure 9. Decreased goblet cell number upon claudin-1 overexpression 
(A) Quantification of goblet cells in colon as measured by PAS and Muc2 
staining/crypt. (B) Further confirmation showed Claudin-1 overexpression induced a 
reduction in Alcian blue staining. ***p<0.001 
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Cl-1Tg mice are susceptible to DSS-colitis and demonstrate impaired 
recovery 
Loss of goblet cells characterizes IBD patient samples(Tytgat et al., 1996) 
and mice with genetic deletion of muc-2 develop spontaneous colitis (van der 
Sluis et al., 2006). Claudin-1 expression is upregulated in areas of active 
inflammation in IBD patients (Weber et al., 2008).  Therefore, in light of the 
dysregulated goblet cell differentiation and decreased muc-2 expression in Cl-
1Tg mice, we further determined whether these mice are susceptible to mucosal 
inflammation/ regeneration/ repair during colitis, using a commonly used DSS-
mouse model of colitis. WT and Cl-1Tg mice were subjected to drinking water 
containing DSS (5% wt/vol) for a period of 7 days followed by regular drinking 
water for 5 days to recover. Mice were weighed daily and monitored for signs of 
distress (see Supplementary Methods).  On day-4 of DSS-treatment, a significant 
body weight loss was observed in the DSS-treated Cl-1Tg mice compared to WT 
mice (p<0.001) and this continued until day-7 of DSS-administration (Figure 
10A). Apart from body weight, we observed a significant increase in the colon 
weight/length ratio (p<0.05) in DSS-treated Cl-1Tg versus WT mice (Figure 10B). 
Histopathological analysis further supported the severity of inflammation in DSS-
treated Cl-1Tg versus WT mice (Figure 11). However these mice did not recover, 
lost more than 20% of body weight by day 9 and were therefore euthanized.  
In further studies, we decreased the dosage of DSS to 3.5% wt/vol, while 
keeping the duration of DSS-administration constant (7 days) followed by regular 
drinking water for 5 days to recover. The DSS-treated Cl-1Tg mice again showed 
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a decrease in body weight as early as day-4 (versus WT mice) and the trend 
continued until day-7 (Figure 10C). The H&E staining showed epithelial damage 
and loss of the crypt structure in DSS-treated WT mice. The epithelial damage 
was enhanced in Cl-1Tg mice and showed severe loss of crypt structure. Most 
interestingly, during the recovery phase, the WT mice showed complete recovery 
of the DSS-colitis dependent body weight loss while Cl-1Tg mice demonstrated 
impaired recovery (Figure 10C).  Furthermore, the recovering Cl-1Tg mice 
exhibited hyperplastic elongated crypts compared to the extensive normal 
regenerative crypts in WT mice (Figure 10D). Histopathological scoring for the 
inflammation, depth of inflammation, and crypt damage confirmed the 
significantly higher degree of the depth of inflammation and epithelial injury in 
DSS-treated Cl-1Tg mice versus WT mice (Figure 10E). Furthermore, during 
recovery, Cl-1Tg mice continued to display high scores for both inflammation and 





Figure 10. Claudin-1 Tg mice are susceptible to DSS-colitis 
WT and Cl-1Tg mice were given DSS (5% w/v) for 7-days and (A) percent change in 
body weight and (B) Colon weight/length (g/cm) in control and DSS-treated animals 
were monitored. Further, WT and Cl-1Tg mice were exposed to DSS (3.5% w/v) for 7-
days and then allowed to recover for 5-days. Following parameters were then 
determined: (C) Percent change in body weight; (D) Representative H&E staining; and 
(E) Histopathologic scoring of the inflammation, depth of inflammation, and crypt 
damage.  Data are represented as the percentage of mice per group with the indicated 






Figure 11. 5% DSS induces severe colitis in WT and Tg mice 
(A)Histopathology score of WT and Tg mice treated with 5% DSS. (B) Representative 
H&E staining of WT and Tg mice treated with DSS. 
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The DSS-treated Cl-1Tg mice demonstrated persistently low muc-2 
expression and an elevated and sustained immune response  
The epithelial and mucosal barrier serve as the prime protective layers 
from luminal antigens (Kufe, 2009). Since, DSS-treated and recovering Cl-1Tg 
mice showed persistent inflammation, we determined the changes in epithelial 
permeability and status of muc-2 expression in these mice. Ussing Chamber was 
utilized to determine the changes in TER and trans-mucosal permeability (Figure 
12). For the integrity of mucus layer, IHC was performed using anti-muc-2 
antibody and number of positively stained, intact cells/crypt was quantified 
(Figure 13A). The TER decreased in both mice groups when subjected to DSS-
colitis however decrease was more pronounced in Cl-1Tg mice (p<0.0001). 
Further, an increasing trend in TER in the recovering WT mice (versus DSS-
colitis group) contrasted with the persistent decrease in Cl-1Tg mice (Figure 12). 
The permeability for FITC-Dextran increased in both mice groups in response to 
DSS-treatment (versus respective controls). However, the trans-mucosal 
permeability demonstrated a reversing trend towards the control levels in the 
recovering WT mice compared to a persistently increased trans-mucosal 
permeability in the recovering Cl-1Tg mice though differences were statistically 





Figure 12. Effect of DSS on colonic transepithelial resistance and FITC 
(FD4) flux 
WT and Tg mice were given DSS and sacrificed on day 4 (DSS) and day 10 (Recovery) 
and the resistance (A) and FD-4 flux (B) across colonic sheets were measured. 
acompared to WT-control, b compared to Cl-1Tg-control, *p<0.05, ***p<0.001 
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Figure 13. Cl-1 Tg mice have sustained inflammation during recovery from DSS-colitis 
WT and Cl-1Tg mice exposed to either water alone, DSS (7 days), or DSS and then switched to regular water (5 days; recovery). These 
mice were then (A) Immunostained and quantitated for muc-2 expression using anti-muc-2 antibody; and (B) Immunostained and 
quantitated for T-cell infiltration using CD3, a T-cell marker, in the colon from control (water), DSS (day-7) and recovery (day-12), WT and 
Cl-1Tg mice. a compared to WT-control, b compared to Cl-1Tg-control, c compared to WT-DSS, d compared to WT-recovery (C) 
Quantitative RT-PCR analysis of TNFα, IFN-γ, KC and IL-10 expression. *p<0.05, **p<0.01, and ***p<0.001.    
 
 42 
We observed decreased muc-2 expression in DSS-treated WT and Cl-1Tg mice 
compared to respective control mice. While muc-2 expression levels recovered to 
control levels (p<0.05) in recovering WT mice, it failed to recover to similar levels 
in the recovering Cl-1Tg mice (p<0.001) (Figure 13A). Furthermore, in Cl-1Tg 
mice the goblet cells in absence of optimal muc-2 synthesis lost their 
characteristic goblet like shape, a characteristic similar to that seen in muc2-/- 
mice earlier (van der Sluis et al., 2006).  
During colitis there is an infiltration of immune cells accompanied by 
changes in cytokine gene expression that occurs in response to the ensuing 
damage (Műzes et al., 2012).  One component of the immune infiltrate is CD3+ 
T-lymphocytes that are critical effectors of the mucosal immune activation. A 
significant increase in CD3+ cells was observed in DSS-treated Cl-1Tg compared 
to WT mice (p<0.001). Again as in muc-2 expression, the increase in CD3+ cells 
infiltration in recovering WT mice returned back to the levels in control (water) 
mice. However, recovering Cl-1Tg mice retained a significantly higher level of 
CD3+ cells (p<0.01; Figure 13B), suggesting sustained immune activation. To 
further define the changes in immune activation, we compared mRNA expression 
levels of the key inflammatory cytokines, TNFα, IFN-γ, IL-10 and chemokine KC/ 
CXCL1 using qRT-PCR. An increased expression of the inflammatory cytokines 
was observed in DSS-treated WT and Cl-1Tg mice. However, Cl-1Tg mice 
showed significantly increased and sustained cytokine production including TNFα 
and IFN-γ even 5-days post-DSS treatment (the recovery phase) when the 
cytokine levels in DSS-treated WT mice had returned to control levels (Figure 
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13C). To further confirm these findings, we examined cytokine protein levels 
using total colon lysates from mice that underwent recovery following DSS-
treatment (Figure 14).  Outcome was consistent with the data from qRT-PCR 
analysis and demonstrated significant increases in TNFα (p<0.05), IL-1β 
(p<0.01), IL-4 (p<0.05) and IP-10 (p<0.01). Thus, our results suggested that 
sustained loss of muc-2 expression and increased cytokine expression in the Cl-




Figure 14. Multiplex Analysis of WT and Tg control and DSS-Recovery mice 
WT and Tg colons were harvested after DSS-Recovery and protein isolates were 
subjected to multiplex analysis. *p<0.05, **p<0.01 
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Proliferation and apoptosis were altered in Cl-1Tg mice following DSS 
treatment and recovery  
In addition to the sustained immune activation, we observed impaired 
epithelial recovery in recovering Cl-1Tg mice while colonic crypts underwent 
hyperplasia. Under similar conditions, WT mice showed normal regenerating 
crypts (Figure 10D). Further determination of the proliferation and apoptosis 
showed sharply decreased cell proliferation while caspase-3 positive cells 
increased in DSS-treated WT mice which was well in accordance with previous 
reports (Araki et al., 2006).  Interestingly, both the DSS-dependent decrease in 
proliferation and the increase in apoptosis were higher in DSS treated Cl-1Tg 
mice compared to control mice (Figure 15A,C&D, p<0.001). In contrast, during 
the recovery, we found no significant difference in the apoptosis between the WT 
and Cl-1Tg mice. At the same time, Cl-1Tg mice demonstrated increased p-
ERK1/2 expression and hyperproliferation compared to WT mice (Figure 15B&C, 
p<0.001). Combined, the dynamic balance between the proliferation and 
apoptosis appeared to be dysregulated in Cl-1Tg mice, which combined with 




Figure 15. Proliferation and apoptosis are altered in Cl-1Tg mice 
undergoing DSS treatment and recovery 
(A) Proliferation was determined using immunohistochemical analysis to determine BrdU 
incorporation in the colon of WT and Cl-1Tg mice exposed to water, DSS and DSS-
recovery; (B) Immunoblot analysis to determine the expression of pERK1/2 and total 
ERK1/2 in colon tissue samples.  Quantification of (C) BrdU+ cells/crypt (50 crypts/mice, 
n=3), and (D) Cleaved caspase-3 positive cells in control, DSS and recovery samples.  a 
compared to WT-control, b compared to Cl-1Tg control, c compared to WT-DSS, d 
compared to WT recovery. *p<0.05, **p<0.01, and ***p<0.001. 
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Notch-signaling is upregulated in Cl-1Tg mice 
The Notch-signaling pathway is the critical regulator of the intestinal 
epithelial cell fate determination (Fre et al., 2011; Nakamura et al., 2007).  Apart, 
Notch-signaling regulates Muc-2 expression (Okamoto et al., 2009),(van der Flier 
and Clevers, 2009), and has a critical role in the regulation of mucosal 
inflammation and proliferation (Okamoto, 2011).  Therefore, we examined the 
status of Notch-signaling (using Hes-1 expression as marker) in DSS-treated and 
recovering WT and Cl-1Tg mice (Figure 16A). Hes-1 expression was higher in 
the control as well as DSS-treated Cl-1Tg mice (versus control or DSS-treated 
WT mice respectively). Interestingly, similar to the muc-2 expression, Hes-1 
expression also reverted back to the control levels in the recovering WT mice. In 
contrast, Hes-1 expression remained increased in the recovering Cl-1Tg mice 
compared to the control and/or DSS-treated Cl-1Tg mice highlighting the inherent 
defect in the regulation of Notch-signaling in these mice. Therefore, we further 
determined the changes underlying Notch-activation in Cl-1Tg mice. To activate 
Notch-signaling, a proteolytic cleavage releases the Notch intracellular domain 
(NICD), which is then transported to the nucleus to induce transcription of a 
number of genes including Hes-1 (Zheng et al., 2011).  Hes-1, inhibits expression 
of Math1 and thus muc-2, both of which are markers of secretory cell lineage 
(Qiao and Wong, 2009).  Using immunoblot and real time qPCR analysis, 
increased NICD and Hes-1 (p<0.01, 2.5-fold) and decreased Math-1 (p<0.001, 3-
fold) expressions were documented in the colon of Cl-1Tg versus WT mice 
(Figure 16B).   
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Figure 16. Increased Notch-signaling in Cl-1Tg mice and colon cancer 
cells during DSS injury and recovery 
(A) Immunostaining for Hes1 expression to determine Notch activity during DSS-
treatment and recovery. (B) Notch activity was assessed via immunoblotting for NICD 
expression and real-time PCR for Hes1 and Math1 in WT and Cl-1Tg colon tissue. 
**p<0.01, ***p<0.001. (C) Notch activity was assessed via immunoblotting for NICD 




We also observed increase in NICD and Hes-1 and a decrease in Math-1 
expression in SW480claudin-1 cells (stably overexpressing claudin-1) (Figure 16C). 
Similar increase in Notch signaling (NICD, Hes-1 and Math-1 expression) was 
observed in goblet cell-like Ls174T cells in response to stable claudin-1 
overexpression (Figure 17A). Claudin-1 overexpression also inhibited the levels 
of PAS-immunostaining and differentiation-associated proteins TFF3 and KLF4 in 
these cells, similar to Cl-1Tg mice (Figure 17B). Inhibition of Notch-signaling 
using DAPT reverted the claudin-1-dependent effects upon differentiation and 
inhibited proliferation in these cells (Figure 17C-E).  
An association of claudin-1 with matrix-metalloproteases and potential role 
in MMP-9 activation is reported (Miyamori et al., 2001).  Therefore, we 
determined the expression of active-MMP-9 in Cl-1Tg mice. Immunoblot analysis 
demonstrated increased expression of active MMP-9 in Cl-1Tg mice (versus WT 
mice, Figure 18A). Increased expression of active-MMP-9 was also observed in 
SW480claudin-1 and LS174Tclaudin-1 cells (Dhawan et al., 2005). Similar to Cl-1Tg 
mice, we also observed increased p-ERK1/2 expression in claudin-1 




 Figure 17. Claudin-1 overexpression alters Notch signaling, proliferation and 
differentiation in colon cancer cells. 
(A) Notch activity was assessed via immunoblotting for NICD and real-time PCR for Hes1 
and Math1 expression in goblet cell-like LS174T cells stably overexpressing claudin-1 
(LS174TClaudin-1). (B) LS174TClaudin-1 and control cells were assessed for changes in goblet 
cell differentiation by PAS immunostaining and qRT-PCR for TFF3 and KLF4.  *p<0.05, 
***p<0.001.(C) LS174TClaudin-1 cells were treated with a γ-secretase inhibitor, DAPT (100μM, 
48h); (C) inhibition of NOTCH activity; (D) Cell proliferation-MTT assay; and differentiation 
was assessed via (E) PAS staining and qRT-PCR for differentiation markers TFF3 and KLF4 
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We then examined functional importance of Notch, MMP-9 and p-ERK1/2 
signaling in claudin-1-dependent effects. Inhibition of MMP-9 activity, using MMP 
specific inhibitor GM6001, inhibited NICD expression and induced differentiation 
in claudin-1 overexpressing Ls174T cells (Figure 18B&C,E,F) without affecting 
the proliferation and p-ERK1/2 expression (Figure 18C&D). Of note, goblet cell 
number increases in MMP-9 knockdown mice (Garg et al., 2007).  Inhibition of 
Wnt/β-catenin signaling (yet another important pathway in intestinal 
differentiation/proliferation) using a specific inhibitor pyruvinium (100nM, 24hrs) 
did not affect the NICD or MMP-9 expression (data not shown). 
We then determined the functional importance of ERK1/2 activation. Inhibition of 
p-ERK1/2, using U0126, inhibited NICD expression while inducing apoptosis 
(cleaved caspase-3 expression) and differentiation. However, inhibition of ERK 




Figure 18. Claudin-1 induced Notch signaling is mediated through the 
regulation of MMP-9. 
(A) Immunoblot and densitometric analysis for MMP-9 expression in the colon of WT and 
Cl-1Tg mice. (B) LS174TClaudin-1 cells were treated with a MMP inhibitor, GM6001 
treatment (40μM, 48h) and effects on MMP-9 and NICD expression were determined in: 
(B) SW480 and SW480claudin-1 cells; (C) LS174T and LS174TClaudin-1 cells; (D) Cell 
proliferation-MTT assay; (E) differentiation (PAS staining and qRT-PCR for 
differentiation markers TFF3 and KLF4). *p<0.05, **p<0.01. (F) Densitometric analysis of 





Figure 19. ERK signaling regulates Notch activation, apoptosis and 
differentiation in Claudin-1 overexpressing cells. 
Ls174Tclaudin-1 cells were treated with U0126 (10μM for 24 hrs.); (A) Immunoblot 
analysis of MMP9, p-ERK, NICD and cleaved caspase-3; (B) cell proliferation-
MTT assay; (C) PAS staining and real-time PCR analysis of differentiation 




Claudin-1 is a key constituent of the tight junction complex, however, 
recent studies, including ours, have highlighted other potential functions of 
claudin-1 (Singh et al., 2012; 2011).  Recent studies have demonstrated marked 
increase in claudin-1 expression in colon cancer (Dhawan et al., 2005) as well as 
the areas of active inflammation and its correlation with neoplastic transformation 
(Kinugasa et al., 2010; Weber et al., 2008).  However, no study to date has 
determined the potential causal role of claudin-1 expression in the regulation of 
mucosal inflammation. In this study, using a novel transgenic mouse model with 
intestinal claudin-1 overexpression, we unravel a novel and previously unknown 
role of claudin-1 in the regulation of Notch-signaling, epithelial differentiation and 
mucosal inflammation.  
Importantly, Notch-signaling is one of the master regulators of colonic 
epithelial differentiation and cell lineage determination of secretory cell lineage, 
especially goblet cells (van der Flier and Clevers, 2009; VanDussen et al., 2012).  
The principal secretory product of goblet cells is muc-2, a key constituent of the 
mucus layer that protects the mucosal epithelial layer (Bergstrom et al., 2010; 
Johansson et al., 2008). Notably, Notch activation and muc-2/goblet cell 
depletion is a characteristic associated with mucosal inflammation and colon 
cancer (Garg et al., 2011; Maloy and Powrie, 2011; Qiao and Wong, 2009; van 
der Sluis et al., 2006; K. Yang et al., 2008; W. Yang et al., 2005).  Thus, it 
becomes important to investigate how Notch-signaling is regulated under 
physiological and pathological conditions. Our data suggest that claudin-1 
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expression may serve as one of the dynamic regulators of Notch-signaling. Our 
studies using qPCR analysis showed that the expression of Notch receptors and 
ligands known to be upregulated in colon cancer (Vooijs et al., 2011)   is not 
altered in Cl-1Tg mice (data not shown). However, inhibition of MMP-9 inhibited 
NICD expression and differentiation. Therefore, we postulate that the increase in 
claudin-1 expression increases proteolytic cleavage of the Notch-receptor to 
release NICD, which in turn translocates to the cell nucleus and regulates the 
transcription of Notch-target genes to regulate the colonocyte differentiation and 
cell fate determination. Importantly, claudin-1 associates with various 
metalloproteinases including MT1MMP and MMP-2 and induces their activation 
(Dhawan et al., 2005; Oku et al., 2006).  While γ-secretase is the known 
regulator of Notch-cleavage, its proteolytic action to cleave Notch is facilitated by 
matrix metalloproteinases (MMPs) including MMP-7 and MMP-9. In this regard, 
MMP-7 was shown to be necessary for γ-secretase mediated Notch1-cleavage in 
pancreatic cells and its downstream effects (Sawey et al., 2007).  Furthermore, 
Notch-activity is modulated in the colon of mice genetically manipulated for MMP-
9 expression/activity (Garg et al., 2007).  Notably, the phenotype of Cl-1Tg mice 
observed in our current study strongly resembles with the phenotype of MMP-9-/- 
mice under normal physiological condition or when subjected to DSS colitis.  
These findings support a role of claudin-1 in the regulation of Notch-signaling and 
colonic homeostasis. Future studies where Cl-1Tg mice are interbred with mice 
manipulated to inhibit Notch-signaling will further clarify such functional 
correlation and is part of our ongoing investigation. 
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Despite the obvious defects in Notch-signaling and altered differentiation, 
we did not observe any gross morphological/developmental defects in Cl-1Tg 
mice. However, when subjected to DSS-colitis and recovery, not only were these 
mice susceptible but also demonstrated sustained immune activation and 
inflammation even when the source underlying this immune-
activation/inflammation (DSS) was removed. Moreover, epithelial regeneration 
and repair was compromised in Cl-1Tg mice when subjected to inflammatory 
insult. Our data shows muc-2 expression remains significantly decreased in 
DSS-treated Cl-1Tg mice. Furthermore, despite baseline increases in TER, the 
DSS-dependent decrease in TER or increase in trans-mucosal permeability were 
relatively pronounced in Cl-1Tg mice. Also, during the recovery decreased muc-2 
expression was accompanied with persistent decrease in TER and increased 
trans-mucosal permeability in Cl-1Tg mice.  Thus, our data suggest that the 
impaired mucosal barrier function and epithelial differentiation may underlie the 
impaired epithelial recovery in DSS-treated Cl-1Tg mice, which in turn may 
underlie the sustained cytokine activation, immune activation and inflammation in 
these mice. Data from muc-2 deficient and MMP-9-/- mice support such a 
postulation as similar sustained immune-activation and hyperproliferation have 
been observed in these mice (Garg et al., 2007; van der Sluis et al., 2006). 
When stimulated with proinflammatory cytokines (including IFN-γ and TNF-α), 
the intestinal epithelial cells may also secrete chemokines, directing migration 
and activation of leukocytes. CXCL10 (IP-10) chemokine, which was significantly 
induced in recovering Cl-1Tg mice compared to the WT mice, chemoattracts 
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activated T-cells as well as monocytes (Fang et al., 2012).  In accordance, we 
observed increased and sustained CD3+ cell infiltration in DSS-treated and 
recovering Cl-1Tg mice. Of interest, IP-10 is upregulated in pathogen-induced 
acute inflammation,(Yeruva et al., 2008) and IFN-γ is the major inducer of IP-10 
(Cassatella et al., 1997).  Furthermore, IL-1β has also been recently shown to 
induce IP-10, especially in combination with TNFα and IFN-γ (Yeruva et al., 
2008).  Notably, in recovering Cl-1Tg mice there was sustained increase in 
TNFα, IL-1β and IFN-γ expression. Combined, we suggest increased cytokines 
and chemokines in recovering Cl-1Tg mice help sustain the inflammation by T-
cell recruitment.  
 Another possibility that may underlie sustained inflammation in Cl-1Tg 
mice is the potential defect in antigen clearance. A relatively compromised 
mucus layer due to the decrease in muc-2 expression could enable enhanced 
passage of luminal antigens in DSS-treated Cl-1Tg mice versus WT mice. An 
impaired recovery in these mice could further help sustain access of the luminal 
antigens into the mucosa (Figure 9 & 12). Apart, we have observed marked 
changes in the expression of claudin-7 in the colon of Cl-1Tg mice. Of interest, 
genetic ablation of claudin-7 results in epithelial cell sloughing, significantly 
higher levels of cytokines, MMP-3 and MMP-7 and spontaneous colitis (Evans et 
al., 2007).  Also, claudin-1 is also a co-receptor for Hepatitis-C-virus (Evans et 
al., 2007). However, further studies are required to ascertain such possibilities.  
Sustained immune activation, dependent injury and subsequent regenerative 
response initiates a vicious cycle leading to chronic inflammation which, in the 
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presence of oncogenic gene mutation, promotes epithelial transformation and 
neoplastic growth. Our findings that Notch and ERK 1/2 activation, and 
proliferation are significantly increased in the colon of Cl-1Tg mice (versus WT 
littermates) and colonic crypts in Cl-1Tg mice demonstrate hyperplasticity during 
the recovery from DSS-colitis suggest that inflammatory mechanisms may help 
promote the role of claudin-1 as colon cancer promoter. Similar claudin-1 
mediated regulation of ERK activation in human liver cells has been 
demonstrated previously (Suh et al., 2012). Co-operation between Notch and 
ERK1/2-signaling in the regulation of proliferation and differentiation has been 
reported (Sundaram, 2005).  Ras-activated breast cancer cells acquire 
tumorigenic properties when Notch signaling is activated (Mittal et al., 2009).  
Furthermore, dysregulated epithelial differentiation and proliferation constitutes 
the core of cancer progression and metastasis. Taken together, central outcome 
from our current study is that claudin-1 regulates colonic epithelial cell 
differentiation in a Notch-dependent manner. Dysregulation of claudin-1 
expression modulates MMP-9 and p-ERK expression/activity to induce Notch-
signaling and dysregulate colonic epithelial homeostasis favoring inflammatory 
conditions and hyperplasia. Our current findings are well in accordance with our 
earlier findings where genetic manipulation of claudin-1 in colon cancer cells had 
inverse effect upon epithelial differentiation (Dhawan et al., 2005).  Taken 
together, our data support a novel role of claudin-1 in the regulation of Notch-





INTESTINAL EPITHELIAL CELL SPECIFIC CLAUDIN-1 EXPRESSION 
ENHANCES SUSCEPTIBILITY to APC-MEDIATED COLON TUMORIGENESIS 
 
Introduction 
Claudin-1 is a member of the claudin family of tight junction family of 
proteins whose traditional roles involve maintenance of the epithelial barrier.  In 
recent years many claudins have been shown to be important players in several 
types of cancers, in capacities beyond barrier regulation, when their expression 
patterns have been altered. In most of these studies, loss of TJ proteins have 
contributed to deregulation of mechanical aspects of tumor progression such as 
migration (Ikari et al., 2011), and invasion (Oku et al., 2006; Zavala-Zendejas and 
Torres-Martinez, 2011).  We and others have shown that the claudin-1 
expression is upregulated in human colon cancer (Dhawan et al., 2005) and that 
modulation of this expression regulates the primary tumor growth and metastasis 
in xenograft models.  It is not quite clear, however, how increased expression of 
claudin-1 contributes to colon tumorigenesis. 
Importantly, in our recent studies, we have demonstrated a role for 
claudin-1 in the maintenance of normal intestinal homeostasis whereby intestinal 
epithelial cell (IEC)-specific constitutive expression of claudin-1 altered goblet cell 
differentiation by promoting Notch activation (Pope et al., 2013).  Importantly, 
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Villin-claudin-1 Tg mice also demonstrated enhanced severity of DSS-induced 
colitis and impaired recovery from colitis-induced epithelial injury, which was 
attributed to the decreased mucosal protection due to loss of the primary 
component of goblet cells and defense, Mucin-2.  This further confirmed a 
previously established connection between inflammation and claudin-1 
expression that has also been shown in studies of active IBD as well as colitis-
associated cancer (Weber et al., 2008), (Kinugasa et al., 2010).    
Sole overexpression of claudin-1, however, was not sufficient to induce 
tumorigenesis in mice. Therefore, to better determine the role of claudin-1 in 
colon tumorigenesis, we crossed the Villin-claudin-1 Tg mouse with the APCMin 
(APC) mouse model of intestinal tumorigenesis. The Min model replicates the 
common mutation inherited in Familial Adenomatous polyposis disease (FAP) 
which predisposes patients to spontaneous colorectal cancer.  Although APC 
mice have been shown to develop adenomas of the small intestine, they rarely 
develop those of large bowel origin (McCart et al., 2008).  Yet much of the work 
performed in these mice has helped make strides in the understanding of colon 
cancer.  Consequently, this model has been widely used to study the role of 
specific genes of interest in colorectal cancer in conjunction with the APC genetic 
mutation, and in some cases have been able to drive colon tumorigenesis.  
Indeed, some instances where colon tumors were initiated in other models of 
APC mediated tumorigenesis involved direct or indirect activation of Notch 
signaling (Fre et al., 2009), (Peignon et al., 2011).   
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Here, we show that claudin-1 overexpression in APC mice causes 
increased tumor development in the colon and decreases survival.  Additionally 
tumors in APC-Cldn1 mice have elevated Wnt signaling and Notch activity due to 
claudin-1 upregulation.  Lastly, increased colon tumorigenesis in these mice 
demonstrates upregulated pro-inflammatory signature including IL-23/IL-17 
immune signaling.  Notably, increased mucosal permeability and bacterial 
translocation, as seen in APC-Cldn1 mice, upregulates IL-23/IL-17 signaling to 
promote colon cancer.  Taken together, our current studies provide a clear 
insight into the role of claudin-1 protein in the regulation of colonic homeostasis 
and colorectal cancer.  
 
Materials and Methods 
 
Mice  
To obtain APCMin/+-Villin-Cldn1 Tg mice (APC-Cldn1), APCMin (APC) 
males, purchased from Jackson Laboratories (Bar Harbor, Maine) were bred with 
Villin-Claudin-1-Tg females.  Claudin-1 overexpression was assessed by PCR as 
described previously (Pope et al., 2013) on genomic DNA isolated from tail snips 
using DNA isolation buffer (Viagen Biotech).  Identification of mutated APC allele 
was performed using a modified protocol from Jackson Laboratories and a set of 
three primers identifying the wild type and mutant alleles. APC and APC-Cldn1 
littermates were monitored for signs of morbidity including hunched posture, 
anemia, and body weight loss and sacrificed according to the guidelines of 
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Vanderbilt University Institutional Animal Care and Use Committee (IACUC).  
Accelerated tumorigenesis was induced by administering 8-10 week old mice 
dextran sulphate sodium in their drinking water.  Mice were monitored throughout 
duration of the experiment as described previously (Pope et al., 2013), and 
examined intermittently via colon endoscopy.  
Tissue Processing 
As described previously, the colon and small intestine were dissected and 
flushed with PBS, opened flat and formalin fixed using the Swiss roll method. 
Further processing was performed by the Vanderbilt Translational Pathology 
Shared Resource Core. Distal and proximal sections of the colon were snap-
frozen and stored at -80°C for further analysis.  Where applicable, colonic tumors 
were quantified.  Tumors were either isolated and frozen for further analysis, or 
left in the colon to be processed for embedding and H&E staining.   
Tumor size measurements 
Tumor area was calculated using Axiovision digital imaging processing 
software by outlining tumors of three to four mice each of APC and APC-Cldn1 
mice.   
Immunohistochemistry  
Immunostaining of paraffin-embedded tissues was performed as 
described previously (Pope et al., 2013) using VectaStain ABC kit (Vector 




Total RNA was isolated from tumors excised from the colon of APC and 
APC-Claudin-1 mice using Qiagen RNAeasy Mini kit with DNAse digestion step 
performed.  The integrity of the RNA was determined by performing 
formaldehyde gel electrophoresis.  Samples displaying two bands, corresponding 
to the 18S and 28S subunits, and having an A260/A280 of ~1.8 were used for 
experiments. 
Microarray Analysis 
Total RNA was isolated from snap-frozen tumors, as described above, 
and RNA integrity was measured.  Samples were submitted to the Vanderbilt 
Microarray Shared Resource for DNA affymetrix array. 
Quantitative reverse transcription-PCR 
Total RNA (1ug) of each sample was reverse transcribed using the iScript 
cDNA Synthesis Kit (Bio-Rad).  Each qRT-PCR reaction contained SYBR Green 
Master Mix, the indicated primer sets and 25ng of cDNA.  Samples were loaded 
in triplicates on 96 well plates and run on a Bio-Rad iCycler. Ct values were 
utilized to calculate fold change and normalization was performed using beta-
actin.  
Permeability Assay 
Assessment of intestinal permeability to 4kDa FITC-dextran was 
performed as described previously (Pope et al., 2013).   
 64 
Bacterial Translocation 
Translocation of bacteria was assessed by detecting the amount of 
bacterial 16S rDNA using qRT-PCR and specific primers for conserved regions 
of the bacterial 16S rDNA (Fu et al., 2011).  Genomic DNA was isolated from the 
distal colon of three mice per group and 25ng was used per reaction.  The mouse 
Selp gene was utilized as normalization gene. 
Statistics 
Statistical analyses were performed using Graphpad Prism software (San 
Diego, CA) for t-test analysis where comparisons between two groups were 
involved.  SPSS software (College Station, TX) was utilized for analyses of 
Logistic regression (for binary outcomes) and Chi2  (for categorical).  P values 




Claudin-1 overexpression increases colon tumorigenesis and decreases 
survival 
Increased claudin-1 expression has been frequently observed in colon 
cancer, however the consequences of the in-vivo upregulation in colonic 
epithelial cells have not been investigated.  To determine the role of claudin-1 in 
colon tumorigenesis, we crossed Villin-Claudin-1-Tg mice with APCMin mice 
(APC) to generate APCMin-Villin-Claudin-1 (APC-Cldn1) mice.  APC mice 
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characteristically develop adenomas in the small intestine with little to no tumor 
occurrence in the colon (McCart et al., 2008).  Among mice that developed 
colonic tumors, we observed that APC-Cldn1 (n=18) mice developed colonic 
tumors at a higher frequency (p=0.0003) than APC mice (n=18) (Figure 20A).   
Endoscopy of mouse colon at 10 weeks of age showed that APC-Cldn1 mice 
develop colonic tumor before APC mice, suggesting a decrease in tumor latency 
(Figure 21).  Interestingly, the few colonic tumors that developed in APC mice 
were localized towards the middle of the colon whereas the tumors in APC-Cldn1 
mice were more distally localized, as shown in Figure 20B.  Upon examination of 
the H&Es, it also appeared that the tumors were larger in APC-Cldn1 mice; 
therefore we measured the size of tumors using imaging analysis software, and 
indeed found a significant increase (p=0.0178) in the tumor area of APC-Cldn1 
mice compared to that of APC (Figure 20C,D).  Histological analysis further 
showed that the APC-Claudin-1 tumors were less differentiated than APC (Figure 
20D).  Additionally, APC adenomas were predominately low grade, while the 
majority of APC-Cldn1 tumors have high-grade dysplasia (p=0.0007) (Table 3). It 
is rare that adenomas of APC mice, originating from the colon or small bowel 
progress to invasive adenocarcinoma, yet we were able to detect an incident of 
invasion in the APC-Cldn-1 mice (Figure 20E, Table 3).  Through routine care 
and observation of the mice, we also noticed that APC-cldn1 mice began 
showing signs of morbidity much sooner than APC mice.  The average life span 
of a Min mouse is approximately six months.  To determine if there was a 
significant difference in survival, we plotted a Kaplan Meir curve and found that 
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APC-cldn1 mice (n=40) have a statistically significant less survival (p=0.0027) 
than APC mice (n=43) (Figure 20F).  As mentioned previously, multiple adenoma 
formation is restricted to the small intestine in the APC model and is thought to 
attribute to their limited life span.  Therefore we thought it important to assess 
whether changes were observed between tumors of the small intestine also 
progress with claudin-1 overexpression. However, we observed no significant 
difference in the intestinal tumor number with claudin-1 overexpression (Figure 
22) and although more APC-Cldn1 mice presented tumors with high-grade 
dysplasia, this difference was not significant (Table 4).  Taken together, these 
results suggest claudin-1 overexpression enhances susceptibility to tumor 
development in the colon of APC mice as well as contributes to tumor 





Figure 20.  Claudin-1 overexpression increases colon tumorigenesis in 
APC mice and decreases survival. 
(A) Increased number of colon tumors in APC-Cldn1 mice. (n=18 APC mice, 
n=17 APC-Cldn1 mice). (B) Representative images of sporadic colon tumors. (C) 
Increased tumor size in APC-Cldn1 tumors. (D) Representative H&E stainings.  
(E) Invading carcinoma in APC-Cldn1 mouse.  (F) Kaplan Meir survival curve 

















Table 3. Comparative Histological Analysis Colon Tumors 
  
APC APC-Cldn1 
Figure 21. APC-Cldn1 tumor appears before those of APC mice 




















Figure 22. Quantification of Small Intestine Adenomas  
Adenomas of small intestine from APC and APC-Cldn1 mice were quantified.  
Table 4.  Comparative Histological Analysis of Small Intestine Adenomas 
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APC-Claudin-1 tumors have increased Wnt/Notch signaling   
An increase in tumor size or number usually results from an increase in 
proliferation and/or an associated decrease in apoptosis.  Therefore to assess 
proliferation, we performed immunostaining for Ki67, a well-known marker of 
cellular proliferation.  We quantified a significant increase (p=0.0125) in tumor 
proliferation of APC-Cldn1 mice compared to APC (Figure 23A).  We observed 
no significant difference in apoptosis as measured by immunostaining for cleaved 
caspase 3 (Figure 24).  As Claudin-1 is a downstream target of Wnt signaling 
(Miwa et al., 2001), and tumors that arise from the loss of APC have constitutive 
Wnt activation, we decided to examine the colonic tumors in each of these mice 
for potential upregulation of the Wnt/β-catenin pathway.  We immunostained 
tumors for β-catenin, the primary effector of Wnt activation, to assess for 
nuclear/cytoplasmic staining, which is an indication of activated β-catenin.  APC-
Cldn1 tumors showed a noticeable increase in nuclear and cytoplasmic staining 
compared to that of APC tumors (Figure 23B). To further assess Wnt 
upregulation, we performed qRT-PCR analysis using total RNA isolated from the 
colonic tumors of APC and APC-Cldn1 and detected increased mRNA 
expression of established Wnt target genes CD44 (p=0.0159), Lgr5 (5-fold 
increase), and Axin2 (3-fold increase) (Figure 23C).  Previously, we have shown 
that intestinal specific overexpression of claudin-1 in mice causes activation of 
Notch signaling (Pope et al., 2013).  Additionally, several studies have shown a 
role for the Notch pathway in colon tumorigenesis and targeted therapy 
(Miyamoto et al., 2013), (Sonoshita et al., 2011).   Indeed, we were able to 
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confirm Notch upregulation in colonic tumors by observing an increase in Hes1 
and significant decrease (p<0.0001) in Math1 mRNA expression (Figure 23D).  
Taken together, we can conclude that increased claudin-1 expression aids in 





Figure 23. Increased proliferation and upregulated Wnt/Notch Signaling 
contributes to increased tumorigenesis in APC-Cldn1 mice 
(A) Immunostaining and quantification of Ki67 shows increased proliferation in 
APC-Cldn1 tumors.  (B) Nuclear/cytoplasmic β-catenin staining is increased in 
tumors of APC-Cldn1 mice compared to APC mice. (C) qRT-PCR analysis of 
Wnt target genes and (D) Notch target genes in tumors of APC and APC-Cldn1 









APC-Claudin-1 tumors have increased inflammation 
To further assess global changes that occur as a result of claudin-1 
upregulation we performed microarray analysis of colonic tumors isolated from 
APC and APC-Cldn1 mice.  Figure 25 shows a list of selected genes that were 
upregulated and downregulated by a factor of at least 1.5 fold or greater in APC-
Cld1 mice.  In accordance with the data shown above, tumors of APC-Cldn1 
mice showed altered expression of genes correlative with increased Wnt and 
Notch activities.   
Additionally, Notch target genes known to regulate mucosal defense were 
shown to be downregulated in APC-Cldn1 tumors.  To validate mRNA expression 
of these genes, we performed qRT-PCR analysis (Figure 26A).  Mucin-2, a 
primary component of goblet cells which has previously been shown to be 
Figure 24. Apoptosis was not significantly altered in tumors from APC-
Cldn1 mice 
Cleaved caspase-3 staining from adenomas of APC and APC-Cldn1 mice. 
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downregulated with claudin-1 overexpression(Pope et al., 2013), was 
significantly decreased (p=0.0022) in APC-Cldn1 tumors.  Kruppel-like factor 4 
(Klf4) and Trefoil factor 3 (Tff3), also known regulators of goblet cell development 
and mucosal defense, were also decreased in APC-Cldn1 tumors (p=0.0031).  
Studies assessing the loss of Muc2 and Klf4 in the role of APC mediated 
tumorigenesis have shown an increase in colon tumorigenesis as a result of 
inflammation (K. Yang et al., 2008) (Ghaleb et al., 2007).  Additionally, we 
observed several genes corresponding to inflammation and the immune 
response in our microarray analysis.  These observations hinted at a possible 
mechanism for tumor progression involving inflammation.  We performed qRT-
PCR analysis for common cytokines upregulated during inflammation and 
observed a significant increase in IL-10 mRNA expression (p=0.0139), with an 
accompanied increase in IP-10 and TNFα (2- and 3-fold increase, respectively) 
(Figure 26B).  These immune regulators have been shown to be upregulated in 





Figure 25. Microarray analysis of APC-Cldn1 vs APC Tumors 
Genes altered with claudin-1 overexpression, with at least 1.5 fold change, involved in 





Figure 26. APC-Cldn1 tumors have Decreased Mucosal Defense and 
Increased Inflammation 
(A) qRT-PCR analysis of mucosal defense genes Muc2, Klf4, and Tff3 and (B) 
inflammatory genes in APC and APC-Cldn1 tumors. *p<0.05, **p<0.005 
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Claudin-1 increases tumorigenesis in DSS driven model of colon 
tumorigenesis 
Colon tumorigenesis can be induced in APC mice by the administration of 
the colitis-inducing Dextran sodium sulfate (DSS) (Tanaka et al., 2005).  This 
chemical activates inflammation, which drives the development of colonic tumors 
in these mice.  We have shown previously that DSS exposure in Villin-Cld-1 Tg 
mice enhance susceptibility to disease. (Pope et al., 2013)  Therefore, to observe 
the effect of claudin-1 overexpression in this model, we treated APC and APC-
Cldn1 mice with 2% DSS drinking water for 5 days.  Subsequently, mice were 
given normal drinking water and allowed to recover for 2 weeks until sacrifice.  
Endoscopic imaging was performed on each mouse on days 5, 8, and 12 
following DSS administration.  Representative endoscopic images show 
increased inflammation and tumor development as early as day 5 in APC-Cldn1 
mice (Figure 27A), compared to those in APC that developed around day 8. The 
total number of colonic tumors was quantified for each mouse at the time of 
sacrifice with APC-Cldn1 mice developing significantly more (p=0.022) tumors 
than APC mice (Figure 27B). Representative H&E images of water and DSS-
treated mice for each group are shown (Figure 27C).  Although histological 
analysis of tumors between APC and APC-Cldn1 mice did not differ significantly, 
we were able to conclude that Claudin-1 overexpression decreased tumor 
latency and increased tumor number in the DSS-APC model of colon 




APC APC-Cldn1 APC APC-Cldn1 
APC APC-Cldn1 
APC   APC-Cldn1 
Figure 27. Claudin-1 overexpression increases tumor number in 
inflammation driven model of tumorigenesis 
(A) Endoscopic images of control (water-treated) and treated (2% DSS) mice at 
the indicated time points, following 7 days of DSS administration. (B) APC-Cldn1 
mice developed significantly more colon tumors than APC mice.  (C) 
Representative H&E images.  *p<0.05 
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Claudin-1 increases epithelial permeability, bacterial translocation, and 
upregulates IL-23 signaling in APC-Cldn1 tumors 
In accordance with its classical role, Claudin-1 has been shown to directly 
alter epithelial permeability (Furuse et al., 2002) (Inai et al., 1999).  Additionally, 
we have shown a baseline increase in colonic epithelial resistance with increased 
claudin-1 expression (Pope et al., 2013).   Therefore, we decided to assess 
barrier integrity in these mice by measuring permeability to FITC-labeled dextran.  
APC mice between the ages of 12 to 14 weeks have increased permeability 
compared to age-matched wild type mice (Puppa et al., 2011).  Here, we wanted 
to determine whether claudin-1 overexpression could increase colonic 
permeability of APC mice.  We observed an increase in permeability to FITC-
dextran as early as ten weeks of age in APC-cldn1 mice, with a significant 
increase (3-fold) observed at 16-18 weeks (Figure 28A), the age at which tumors 
were found to be present in the colon. Increased permeability in the gut has been 
frequently linked to increased microbial translocation (Ulluwishewa et al., 2011) 
(Bergstrom et al., 2010). Using genomic DNA isolated from mice (4 months of 
age, 3 mice each), we measured translocation via PCR analysis of bacterial 
specific 16S RNA and observed a significant increase (p=0.0129) with claudin-1 







Figure 28. APC-Cldn1 mice have increased colonic permeability and 
bacterial translocation 
(A) Permeability to FITC-dextran via rectal administration at 6-8 weeks (n=5, 6) and 
(B) 14-16 weeks in APC and APC-Cldn1 mice (n= 6 7).  (C) qRT-PCR analysis of 





Recent studies have shown that increased inflammation, specifically IL-23/IL-17 
signaling, contributes to tumor development due to increased permeability and 
bacterial translocation (Grivennikov et al., 2012).  Additionally, presence of IL-23 
facilitates bacterial induced colitis (Buonomo et al., 2013).  We assessed our 
model for upregulation of IL-23 signaling, and indeed, microarray analysis 
showed a significant increase in IL23a cytokine (Figure 25).  Validation by qPCR 
showed a significant increase (p=0.0022) in IL23 specific p19 subunit (Figure 29).  
Additionally, downstream targets IL17A (p=0.0442) and IL6 (4-fold induction) 
were also upregulated in APC-Cldn1 mice.  To further analyze IL23 signaling, we 
performed Immunostaining for phospho-STAT3.  Taken together, these results 
suggests increased claudin-1 expression causes an increase in intestinal 
permeability in APC mice, thus increasing bacterial translocation.  Additionally in 





Figure 29. IL-23 signaling is upregulated in tumors of APC-Cldn1 
mice 
qRT-PCR analysis of IL23 pathway associated genes in APC and APC-Cldn1 




Claudin-1 overexpression has been frequently observed in colon cancer, 
and mucosal inflammation, however the significance of its upregulation has not 
been fully studied. We utilized the APCMin model of colon cancer to identify the 
role of claudin-1 in tumorigenesis and were able to determine that claudin-1 
overexpression contributes to tumor growth and progression (Figure 20, Table 3). 
Not only was there an increase in the amount of tumors, but an increase in size 
was also observed.  As mentioned previously, APC mice do have a limited life 
span, which is often attributed to the tumor burden of the small intestine and 
cachexia that develops as a result.  As we did not observe a difference in small 
bowel tumor number, we believe it is the advanced nature of the colonic tumors 
that contributes to the decreased survival in these mice.   
 The Wnt and Notch pathways have very important roles in normal colonic 
development and are known to be dysregulated in disease, most notably 
colorectal cancer.  Claudin-1 is a known target of Tcf/Lef signaling however also 
seems to participate in potentiation of the pathway as we have seen further 
upregulation of Wnt signaling in the APC-Cldn1 tumors (Figure 23).  This also 
supports our previously published data of claudin-1 regulating E-cadherin 
expression through modulation of Wnt/β-catenin activity (Singh et al., 2011).  It is 
of interest to note the Wnt target genes that are upregulated with claudin-1 
expression are involved in stem cell maintenance (Figure 23C), as opposed to 
those that are well known oncogenes, cyclin D1 and c-myc, of which we 
observed no change in mRNA expression (data not shown). CD44 has been 
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shown to be a marker of cancer stem cells and responsible for conferring 
tumorigenic properties to cells (Du et al., 2008), (Zeilstra et al., 2008).  Lgr5 is an 
established intestinal stem cell marker and has also been shown to regulate 
tumorigenic capacity of colon cancer cells (Barker et al., 2007), (Hirsch et al., 
2013).  Although not identified as a stem cell marker, Axin2 is an established 
target of Wnt signaling whose expression has been shown to contribute to colon 
cancer cell invasion (Wu et al., 2012).   Further studies would establish whether 
claudin-1 could directly regulate expression of these genes.   
In previous studies we showed that claudin-1 increases notch activity.  We were 
able to detect increased notch activity as measured by Hes1 and Math1 mRNA 
expression (Figure 23D).  As crosstalk between the Notch and Wnt pathways is 
not a new concept, it is possible that claudin-1 could rest at the hub of this 
interaction.  The microarray presented several shared genes (Figure 25) between 
these pathways that were upregulated in tumors from APC-Cldn1 mice. 
Additionally, Lgr5 expression, which was increased by claudin-1 overexpression, 
can regulate Notch activity (Hirsch et al., 2013).  
 We have shown in Cldn-1-Tg mice and colon cancer cell lines that 
increased claudin-1 expression can decrease expression of mucosal defense 
genes Muc2, KLF4 and Tff3 (Pope et al., 2013) and in this study microarray data 
and qPCR analysis confirmed downregulation of these genes in the tumors of 
APC-Cldn1 mice (Figure 26A).  These genes, known to be important in the 
protection against inflammation and luminal antigens, have also been shown to 
be important in the protection against tumorigenesis.  Klf4 expression can 
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regulate tumor growth in mouse xenograft studies and tumor number in APC 
mediated tumorigenesis (Zhang et al., 2006), (Ghaleb et al., 2007).  Similarly, 
Tff3 expression can also regulate tumor growth(Uchino et al., 2000).  Muc2 
deficient mice, known to develop spontaneous colitis, have been shown to 
robustly increase colon tumorigenesis when combined with APC mutation (K. 
Yang et al., 2008). Interestingly, partial loss of Muc2 contributed to tumor 
development in APC mice in a similar fashion to claudin-1 overexpression.  
These studies further support Claudin-1 expression can regulate defense gene 
expression and their loss contributes to claudin-1 mediated tumorigenesis.  
Additionally this provides further support of a potential role for inflammation.  We 
confirmed increased expression of cytokines commonly upregulated during 
inflammation in APC-Claudin-1 tumors (Figure 26B).  
Sporadic cancer and colitis-associated cancer are frequently studied as two 
distinct processes separated by their initiating stimulus, loss of APC or 
inflammatory bowel disease, respectively.   Studies, including this work, have 
highlighted a cooperation of the two, beyond genetic manipulation of specific 
inflammatory mediators (Grivennikov et al., 2012), (K. Yang et al., 2008), (H. 
Suzuki et al., 2012), (Chae et al., 2010).  This suggests that whereas 
inflammation is generally thought to be a result of host response to tumor 
development in “hereditary” development of colon cancer, it may actually function 
to fuel tumor progression.  We employed a model that accelerates the formation 
of colonic tumors in APC mice to further examine the role of claudin-1 in 
tumorigenesis (Figure 27).  With this model we were able to track tumor 
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development in both APC and APC-Cldn1 mice in a shorter amount of time.  
Colon tumors were significantly increased and we also observed that in this 
model APC-Cldn1 mice developed tumors earlier than APC mice, further 
confirming our results from the sporadic model (Figure 21).   
Loss of mucosal defense genes and the resulting increased inflammation 
are factors that can be regulated by a breech in barrier dynamics.  The role of 
claudin-1 in the regulation of barrier function was established shortly after its 
discovery.  Additionally, APC mice are inherently more permeable than WT mice. 
Claudin-1 overexpression was able to enhance permeability (Figure 28A).  This 
change in permeability allows commensal bacteria to freely flow into the lumen of 
intestinal epithelium.  There are studies that show bacteria can contribute to 
colon tumorigenesis.  Specifically, APC mice housed in a germ-free environment 
produced less tumors than those placed in normal housing conditions(Dove et 
al., 1997).  APC-Cldn1 mice exhibited increased bacterial translocation, further 
supporting a role for the aid of commensal bacteria in sporadic tumorigenesis.  
Recently, studies involving a separate model of Apc Cre-mediated colon 
tumorigenesis showed that tumor formation was mediated by IL-23 signaling in 
response to barrier defect and increased bacterial products (Grivennikov et al., 
2012). Indeed we observed increased IL-23 and its downstream targets, IL-17 
and IL-6 (Figure 29).  Since IL-23 signaling is activated in response to bacteria, it 
is possible in this model that inflammation arises downstream of claudin-1 
activation in response to increased bacterial translocation.  It is also of interest to 
note that supernatants of colonic ex vivo explants from Muc2/APC mice had 
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increased IL-23 secretion (K. Yang et al., 2008).  Additionally, many of the genes 
found to be upregulated in the microarray of APC-Cldn1 mice were also found to 
be upregulated in the microarray of Muc2/APC mice. 
Studies into the role of tight junction proteins in cancer have focused on 
their role in mechanical aspects of tumorigenesis, i.e., migration and invasion, 
which is not surprising considering the classical function of these proteins.  It is 
ideal to think of alterations in tight junctions affecting latter stages of 
tumorigenesis as it relates to loss of polarity and contribution to EMT-like 
changes, thus facilitating metastasis.  Our work shows a causative role of 
claudin-1 in earlier stages tumorigenesis.  We have shown that increased 
expression of a tight junction protein can increase colonic tumorigenesis in APC 
mice through IL-23 signaling in response to enhanced permeability and 
increased bacterial translocation.  This observation suggests claudin-1 has an 
active role in progressing tumorigenesis as opposed to being altered as a result.  
It is still unclear as to the sequence of events during tumorigenesis in relation to 
the order of inflammation and claudin-1 upregulation.  It is possible to 
hypothesize a feedback loop may exist that maintains elevated inflammation.  
Claudin-1 expression has been shown to be regulated by inflammation (Shiozaki 
et al., 2012),(Weber et al., 2008), and here we have shown that claudin-1 can 
mediate inflammation through a mechanism involving reduced Muc2 and 
increased bacterial translocation.  Further studies will investigate the specific 
mechanism by which claudin-1 upregulates IL-23 signaling beyond bacterial 
upregulation.  This study identifies an essential role of increased claudin-1 
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expression to colon tumorigenesis and provides further insight into the 











CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Claudin-1 is a key component of the junctional adhesion complex and its 
contribution to the epithelial barrier has been well established. For the past 
several years, there have been studies highlighting the dysregulation of claudin-1 
in inflammation and cancer. Specifically, claudin-1 expression has been shown to 
be upregulated in active IBD and in colorectal cancer.  However the specific 
contribution of its increased expression has not been fully elucidated.  Therefore, 
the goal was to determine how claudin-1 overexpression contributes to 
inflammatory bowel disease and colorectal cancer.  
 Many signaling pathways and cellular processes involved in development 
and cell maintenance are commandeered by the cell for use in the progression of 
disease.  In accordance with this fact, I was able to elucidate a novel role for 
claudin-1 in differentiation of the colonic epithelium.  Overexpression of claudin-1 
resulted in decreased number of goblet cells and its primary constituent, Muc2 
(Figure 8).  The implication of this finding proved paramount to the subsequent 
findings in support of my study, highlighting the role of claudin-1 in inflammation 
and cancer.  Muc2 is a key component of mucosal defense and has been 
extensively studied in its connection to inflammation and colorectal cancer.  
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Muc2 deficiency leads to spontaneous colitis (van der Sluis et al., 2006) and 
genetic combination of Muc2 loss with APC mutation leads to accelerated tumor 
formation in mice as a result of increased inflammation(K. Yang et al., 2008).  
Interestingly this effect was found to be dose dependent, as haploinsufficiency of 
Muc2 produced milder effects in the APCMin mouse compared to total loss.  
Intestinal overexpression of claudin-1 mimics the effect of partial Muc2 
expression, in that mice were able to “normally” develop without overt 
physiological defects and reach maturity without acquiring spontaneous disease, 
yet upon stimulus (DSS and APC mutation) was able to enhance susceptibility to 
disease.  Induction of experimental colitis in Cl1-Tg mice caused increased 
epithelial damage and inflammation compared to WT mice (Figure 10).  
Additionally, recovery from DSS-induced colitis was impaired in Cl1-Tg mice, as 
mice were unable to clear the elevated immune response to damage (Figure 13).  
These studies not only uncovered a role for claudin-1 in the development of IBD, 
but also a potential role in epithelial repair. As IBD is a chronic disorder, involving 
repeated cycles of injury and repair, it is important to fully understand the role of 
claudin-1 in epithelial restitution.  Further studies will seek to confirm involvement 
of claudin-1 in regenerating epithelium.  Specifically, we hope to investigate how 
increased claudin-1 expression affects epithelial repair, and whether this may 
prove to be a target of therapy for patients during the active phase of IBD. 
 I was also able to identify additional mechanisms and novel interactions in 
the intestine resulting from claudin-1 overexpression. In line with other studies, 
claudin-1 overexpression was able to increase proliferation through pERK 
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signaling and Notch activity (Figure 17) (Kondo et al., 2008). Most significantly, I 
was able to uncover a mechanism by which claudin-1 regulates Muc2 production 
and goblet cell differentiation, through activation of Notch signaling through 
MMP9 (Figure 18).  Additionally, elevated Notch signaling was observed in 
tumors of APC-Cldn1 mice by microarray and qRT-PCR analysis (Figures 23D, 
25).  Targeting Notch pathway components has proven to be successful in the 
inhibition of tumor growth and development (Miyamoto et al., 2013).  To this end, 
pharmacological and/or genetic inhibition of Notch signaling prior to tumor 
development in APC-Cldn1 mice, or DSS administration in the accelerated 
APCMin model, would help to determine the extent of the role of Notch signaling in 
tumorigenesis mediated by claudin-1 overexpression.  
 Epithelial barrier function is paramount to the maintenance of epithelial 
homeostasis and the prevention of disease.  Increased expression of claudin-1 in 
vitro was shown to illicit an increase in epithelial resistance (Inai et al., 1999).  
Global depletion of claudin-1 proved detrimental in vivo, causing excessive 
dehydration of the skin (Furuse et al., 2002).  Both of these studies were key in 
establishing the function of claudin-1 in its physiologic role as a tight junction 
protein.  Indeed, as these studies would predict, we observed a baseline 
increase in the TER with increased claudin-1 expression (Figure 12).  But, 
surprisingly, this was not sufficient to protect against disease. An external 
stimulus (DSS and APC mutation) was needed to breech barrier function 
(Figures 12 and 28), and claudin-1 overexpression was able to enhance these 
changes. Compared to wild type mice, APC mice begin to exhibit increased 
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permeability as early as 8 weeks of age.  By 4 months of age, APC-Cldn1 mice 
demonstrated nearly a four-fold increase in permeability to FITC-dextran (Figure 
28B).  It is also at this age where tumors were observed in APC-Cldn1 mice.  
Indeed, recent studies have shown that colonic tumors, themselves, have 
increased permeability to FITC-Dextran (Grivennikov et al., 2012), suggesting 
that the increased permeability in APC-Cldn1 mice may be due to increased 
tumorigenesis.  Additionally, we have shown that claudin-7 expression is altered 
upon overexpression of claudin-1 (Figure 5).  Decreased claudin-7 expression 
has been linked to defective intestinal architecture which contributed to instances 
of defective barrier function in older mice, and an increased inflammatory 
response (Ding et al., 2012). Coincidentally, claudin-7 reduction has also been 
associated with increased tumorigenesis (Darido et al., 2008), (Lioni et al., 2007). 
This suggests potential interplay between claudin-7 and claudin-1.  Therefore, we 
would like to determine whether claudin-7 mediates claudin-1 induced barrier 
defect.  Additionally, claudin-7 loss may also mediate tumor progression in APC-
Cldn1 mice.  Of interest, claudin-1 expression has been shown to regulate Zeb-1, 
which is responsible for transcriptional regulation of E-cadherin (Singh et al., 
2011).  E-cadherin is one of the major proteins of the adherens junction complex.  
Loss of E-cadherin is one of the classical markers of cellular transformation, and 
loss of cell polarity.  These processes are also effectors of epithelial barrier 
integrity. 
The contribution of the commensal bacteria in development and 
progression of disease has been increasingly studied.  An increase in bacterial 
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translocation was observed in APC-Cldn1 mice at 4 months of age, which 
correlates with tumorigenesis in these mice.  Colonic tumors of APC mutant mice 
were shown to have increased permeability to bacteria via immunostaining 
(Grivennikov et al., 2012). Additionally, bacteria are able to contribute to tumor 
growth (Li et al., 2012), barrier defects (Barreau and Hugot, 2014), and 
inflammation.  We have yet to determine the extent of bacterial translocation in 
DSS-colitis with claudin-1 overexpression, which would also identify an additional 
mechanism whereby Cld-1-Tg mice are more susceptibility to disease.  
As mentioned previously, claudin-1 overexpression was able to enhance 
susceptibility to disease and impair recovery from DSS-colitis.  When combined 
with APC mutation, we also observed an upregulation of inflammatory 
components and immune regulators via microarray analysis in tumors generated 
from APC-Cldn1 mice.  More importantly we were able to validate increased IL-
23 signaling. Studies have identified IL-23/IL-17 signaling as a contributing factor 
in colon tumorigenesis (Grivennikov et al., 2012), (H. Suzuki et al., 2012).  As we 
have established a connection between increased claudin-1 expression and 
downregulation of muc2, it is also supportive that tumor explants from 
APC/Muc2-/- mice had increased IL-23 secretion (K. Yang et al., 2008).  IL23 
signaling is also upregulated in response to bacteria.  It is unclear how increased 
expression of claudin-1 upregulates IL-23 signaling. Further studies would seek 
to identify the mechanism that mediates claudin-1 induced IL-23 signaling.  As 
claudin-1 has been shown to modulate muc2, it is possible that muc2 loss could 
mediate IL-23 upregulation.  
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As we have identified roles for claudin-1 upregulation in colitis and CRC, 
we have yet to determine the exact stimulus responsible for the increased 
expression of claudin-1 and its subsequent mislocalization.  Several studies have 
provided possible mechanisms however neither have fully elucidated the 
sequence of events in relation to pathogenesis.  Claudin-1 expression has been 
shown to be upregulated in cancer cell lines by cytokine exposure and contribute 
to cells tumorigenic capacity (Kondo et al., 2008), (Shiozaki et al., 2012).  
However, here we have shown that increased expression of claudin-1 may 
precede increased cytokine upregulation by decreasing mucosal defense.  This 
suggests there may be a potential feedback loop in which upregulated claudin-1 
expression is maintained by inflammation, which is sustained by decreased 
components of the mucosal barrier. 
Mislocalization of claudin-1 has been observed in active IBD, colitis-
associated cancer, and primary tumor and metastatic lesions of spontaneous 
CRC.  Several mechanisms may be at play to facilitate claudin-1 mislocalization. 
It is possible that an initiating stimulus could cause a change in claudin-1 
expression while a separate factor could be responsible in the mislocalization of 
claudin-1.  The relationship between APC and claudin-1 is particularly one of 
interest that requires further investigation.  Previous research in our laboratory 
has identified an association between claudin-1 upregulation and mutant APC.   
Additionally, claudin-1 has been shown to associate with Rabs, and additionally 
during physiological conditions is trafficked to and from the membrane via 
endosomes.  Therefore, it is possible that claudin-1 mislocalization could result in 
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a trafficking defect. Each of these processes have roles in colon cancer, and 
therefore may also be exploited in inflammation and cancer to regulate claudin-1.  
 We and others have proposed claudin-1 to be an ideal therapeutic target 
in colon cancer and IBD, as genetic manipulation can regulate tumorigenicity of 
colon cancer cells.  Understanding the specific contribution of increased claudin-
1 expression would allow us to infer when is the best time for treatment.  At least 
in the context of cancer, increased claudin-1 expression caused tumors to 
develop earlier and to progress to an advanced diseased state.  Through this 
study, not only were we able to identify roles for claudin-1 in inflammation and 
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